title: The benefits of HIV resistance testing in optimizing drug discovery.
authors.affiliation: Inflammatory and Viral Diseases Unit, Roche BioSciences, 3401 Hillview Ave., Palo Alto, CA 94304, USA. gabrielle.heilek-snyder@roche.com
authors.forename: Gabrielle
authors.initials: G
authors.lastname: Heilek-Snyder
authors.forename: Pamela
authors.initials: P
authors.lastname: Bean
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D015195:Drug Design; D024882:Drug Resistance, Viral / Q000235:genetics; D006678:HIV / Q000187:drug effects / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation
chemical_list: D019380:Anti-HIV Agents